Description
HULIO (adalimumab biosimilar) is a tumor necrosis factor (TNF) inhibitor used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. It helps reduce inflammation by blocking TNF-alpha.
Reviews
There are no reviews yet.